Puriblood Medical Co., Ltd. (TPEX:6847)

Revenue by Product

Financials in millions TWD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
High-end Blood Purification-related Medical Equipment and Animal Blood Transfusion Product	51.37M
High-end Blood Purification-related Medical Equipment and Animal Blood Transfusion Product Growth	-52.15%
Royalty	42.96M
Royalty Growth	297.74%
Commissioned Technology Development	16.00M
Commissioned Technology Development Growth	128.57%
Other	345.00K
Other Growth	234.95%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Taiwan	100.79M
Taiwan Growth	-14.25%
Other	9.88M
Other Growth	27.90%